16.1%
Ischaemic heart diseases was principal cause of death in 2022, with 20,322 deaths of medically certified deaths1
Department of Statistics Malaysia
Cardiovascular Disease
A top healthcare concern for the nation, a steady demand for therapies
Cardiovascular disease impacts a significant proportion of Malaysians, thus requiring a continuous supply of medicines and therapies to manage the health of patients.
A growing risk
In Malaysia, cardiovascular disease has been the leading cause of morbidity and mortality for more than a decade, with patients also developing the condition at a younger age compared to neighbouring countries.
Risk factors for cardiovascular disease are common in Malaysia, such as being overweight or obese, smoking, hypercholesterolaemia, hypertension and diabetes. Among Malaysian adults, many have clusters of the risk factors for cardiovascular disease.
As of November 2021, 43.2% of adults had at least two of the risk factors.2
Risk to adults aged over 30
in Malaysia
Deaths by Gender, in 2022
9262
Male
2813
Female
Main Cause of Death by Age Group, in 2022
20
Percentage of alldeaths in
adults aged
41 to 59
adults aged
41 to 59
16.7
Percentage of all deaths in
adults aged
60 and over
adults aged
60 and over
Risk by Population Distribution
Risk by Ethnicity
Our Therapies
The demand for effective medicines to help Malaysians with cardiovascular disease maintain their health remains steady in light of the prevalence of the condition. Among our portfolio of classic and specialty pharmaceutical drugs for the domestic and international market are generic drugs to treat cardiovascular disease, such as Vascor, Acetan, Covasc, Crystorvas, Bezartan, Vytan and Vytocor.
